Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective

H. H. Parving, J. B. Lewis, M. Ravid, G. Remuzzi, L. G. Hunsicker

Research output: Contribution to journalArticle

Abstract

We described the characteristics in a referred cohort of type II diabetic patients in the Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes study evaluating the global prevalence and determinants of microalbuminuria (MA). A cross-sectional study evaluating 32 208 type II diabetic patients without known albuminuria from 33 countries was performed. Overall, 8057 patients were excluded, either because of prior known proteinuria or non-diabetic nephropathy (3670), or because of invalid urine collections (4387). One single random urinary albumin/creatinine ratio was obtained in 24 151 patients (75%). The overall global prevalence of normo-, micro-, and macroalbuminuria was 51, 39, and 10%, respectively. The Asian and Hispanic patients had the highest prevalence of a raised urinary albumin/creatinine ratio (55%) and Caucasians the lowest (40.6), P2 in 22% of the 11 573 patients with available data. Systolic BP below 130 mmHg was found in 33 and 43% had an HbA1c below 7%. The frequency of patients receiving aspirin was 32%, statins 29%, and BP-lowering therapy 63%. A high prevalence globally of MA and reduced kidney function, both conditions associated with enhanced renal and cardiovascular risk, was detected in type II diabetic patients without prior known nephropathy. Early detection, monitoring of vascular complications, and more aggressive multifactorial treatment aiming at renal and vascular protection are urgently needed.

Original languageEnglish
Pages (from-to)2057-2063
Number of pages7
JournalKidney International
Volume69
Issue number11
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Kidney
Blood Vessels
Albumins
Creatinine
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Urine Specimen Collection
Albuminuria
Proteinuria
Hispanic Americans
Aspirin
Cross-Sectional Studies
Education
Therapeutics

Keywords

  • Blood pressure
  • Kidney function
  • Microalbuminuria
  • Type II diabetes

ASJC Scopus subject areas

  • Nephrology

Cite this

Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients : A global perspective. / Parving, H. H.; Lewis, J. B.; Ravid, M.; Remuzzi, G.; Hunsicker, L. G.

In: Kidney International, Vol. 69, No. 11, 06.2006, p. 2057-2063.

Research output: Contribution to journalArticle

Parving, H. H. ; Lewis, J. B. ; Ravid, M. ; Remuzzi, G. ; Hunsicker, L. G. / Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients : A global perspective. In: Kidney International. 2006 ; Vol. 69, No. 11. pp. 2057-2063.
@article{e699f76930be4d5488928707977bcf24,
title = "Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective",
abstract = "We described the characteristics in a referred cohort of type II diabetic patients in the Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes study evaluating the global prevalence and determinants of microalbuminuria (MA). A cross-sectional study evaluating 32 208 type II diabetic patients without known albuminuria from 33 countries was performed. Overall, 8057 patients were excluded, either because of prior known proteinuria or non-diabetic nephropathy (3670), or because of invalid urine collections (4387). One single random urinary albumin/creatinine ratio was obtained in 24 151 patients (75{\%}). The overall global prevalence of normo-, micro-, and macroalbuminuria was 51, 39, and 10{\%}, respectively. The Asian and Hispanic patients had the highest prevalence of a raised urinary albumin/creatinine ratio (55{\%}) and Caucasians the lowest (40.6), P2 in 22{\%} of the 11 573 patients with available data. Systolic BP below 130 mmHg was found in 33 and 43{\%} had an HbA1c below 7{\%}. The frequency of patients receiving aspirin was 32{\%}, statins 29{\%}, and BP-lowering therapy 63{\%}. A high prevalence globally of MA and reduced kidney function, both conditions associated with enhanced renal and cardiovascular risk, was detected in type II diabetic patients without prior known nephropathy. Early detection, monitoring of vascular complications, and more aggressive multifactorial treatment aiming at renal and vascular protection are urgently needed.",
keywords = "Blood pressure, Kidney function, Microalbuminuria, Type II diabetes",
author = "Parving, {H. H.} and Lewis, {J. B.} and M. Ravid and G. Remuzzi and Hunsicker, {L. G.}",
year = "2006",
month = "6",
doi = "10.1038/sj.ki.5000377",
language = "English",
volume = "69",
pages = "2057--2063",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients

T2 - A global perspective

AU - Parving, H. H.

AU - Lewis, J. B.

AU - Ravid, M.

AU - Remuzzi, G.

AU - Hunsicker, L. G.

PY - 2006/6

Y1 - 2006/6

N2 - We described the characteristics in a referred cohort of type II diabetic patients in the Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes study evaluating the global prevalence and determinants of microalbuminuria (MA). A cross-sectional study evaluating 32 208 type II diabetic patients without known albuminuria from 33 countries was performed. Overall, 8057 patients were excluded, either because of prior known proteinuria or non-diabetic nephropathy (3670), or because of invalid urine collections (4387). One single random urinary albumin/creatinine ratio was obtained in 24 151 patients (75%). The overall global prevalence of normo-, micro-, and macroalbuminuria was 51, 39, and 10%, respectively. The Asian and Hispanic patients had the highest prevalence of a raised urinary albumin/creatinine ratio (55%) and Caucasians the lowest (40.6), P2 in 22% of the 11 573 patients with available data. Systolic BP below 130 mmHg was found in 33 and 43% had an HbA1c below 7%. The frequency of patients receiving aspirin was 32%, statins 29%, and BP-lowering therapy 63%. A high prevalence globally of MA and reduced kidney function, both conditions associated with enhanced renal and cardiovascular risk, was detected in type II diabetic patients without prior known nephropathy. Early detection, monitoring of vascular complications, and more aggressive multifactorial treatment aiming at renal and vascular protection are urgently needed.

AB - We described the characteristics in a referred cohort of type II diabetic patients in the Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes study evaluating the global prevalence and determinants of microalbuminuria (MA). A cross-sectional study evaluating 32 208 type II diabetic patients without known albuminuria from 33 countries was performed. Overall, 8057 patients were excluded, either because of prior known proteinuria or non-diabetic nephropathy (3670), or because of invalid urine collections (4387). One single random urinary albumin/creatinine ratio was obtained in 24 151 patients (75%). The overall global prevalence of normo-, micro-, and macroalbuminuria was 51, 39, and 10%, respectively. The Asian and Hispanic patients had the highest prevalence of a raised urinary albumin/creatinine ratio (55%) and Caucasians the lowest (40.6), P2 in 22% of the 11 573 patients with available data. Systolic BP below 130 mmHg was found in 33 and 43% had an HbA1c below 7%. The frequency of patients receiving aspirin was 32%, statins 29%, and BP-lowering therapy 63%. A high prevalence globally of MA and reduced kidney function, both conditions associated with enhanced renal and cardiovascular risk, was detected in type II diabetic patients without prior known nephropathy. Early detection, monitoring of vascular complications, and more aggressive multifactorial treatment aiming at renal and vascular protection are urgently needed.

KW - Blood pressure

KW - Kidney function

KW - Microalbuminuria

KW - Type II diabetes

UR - http://www.scopus.com/inward/record.url?scp=33646771273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646771273&partnerID=8YFLogxK

U2 - 10.1038/sj.ki.5000377

DO - 10.1038/sj.ki.5000377

M3 - Article

C2 - 16612330

AN - SCOPUS:33646771273

VL - 69

SP - 2057

EP - 2063

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 11

ER -